International Urology and Nephrology Journal Impact Factor & Information

Publisher: Springer Verlag

Journal description

International Urology and Nephrology publishes original papers on a broad range of topics in urology nephrology and andrology. The journal integrates papers originating from clinical practice. In addition to the regular papers book reviews also form an essential feature of the journal. International Urology and Nephrology is published at bimonthly intervals.

Current impact factor: 1.52

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 1.519
2013 Impact Factor 1.293
2012 Impact Factor 1.325
2011 Impact Factor 1.471
2010 Impact Factor 1.567
2009 Impact Factor 1.053
2008 Impact Factor 0.912
2007 Impact Factor 0.482
2006 Impact Factor 0.53

Impact factor over time

Impact factor

Additional details

5-year impact 1.39
Cited half-life 5.10
Immediacy index 0.28
Eigenfactor 0.01
Article influence 0.37
Website International Urology and Nephrology website
Other titles International urology and nephrology (Online)
ISSN 0301-1623
OCLC 45496589
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Springer Verlag

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's pre-print on pre-print servers such as
    • Author's post-print on author's personal website immediately
    • Author's post-print on any open access repository after 12 months after publication
    • Publisher's version/PDF cannot be used
    • Published source must be acknowledged
    • Must link to publisher version
    • Set phrase to accompany link to published version (see policy)
    • Articles in some journals can be made Open Access on payment of additional charge
  • Classification
    ​ green

Publications in this journal

  • Samiha Hayek · Deepak Batura
    International Urology and Nephrology 10/2015; DOI:10.1007/s11255-015-1122-x
  • Crina Claudia Rusu · Simona Racasan · Ina Maria Kacso · Liviu Ghervan · Diana Moldovan · Alina Potra · Ioan Mihai Patiu · Cosmina Bondor · Mirela Gherman Caprioara
    International Urology and Nephrology 10/2015; DOI:10.1007/s11255-015-1114-x
  • International Urology and Nephrology 09/2015; DOI:10.1007/s11255-015-1076-z
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hemorrhagic cystitis is a rare and severe late complication of pelvic radiation, and there is no regulatory-approved drug treatment. We present an 81-year-old man with a history of localized prostate cancer, which was treated with external beam radiation therapy and subsequently developed severe hemorrhagic radiation cystitis for which he has failed several treatments. We present the novel use of intravesical tacrolimus for the treatment of refractory radiation cystitis and gross hematuria. The patient tolerated the treatment well, and it resulted in the resolution of his gross hematuria without further consideration for formalin instillation or cystectomy and diversion. Intravesical tacrolimus is a safe, minimally invasive, and promising treatment option for radiation hemorrhagic cystitis.
    International Urology and Nephrology 09/2015; DOI:10.1007/s11255-015-1098-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effect of adjuvant radiation therapy on survival in sarcomatoid renal cell carcinoma (sRCC) with no evidence of distant metastasis remains unclear. Subjects diagnosed with non-metastatic sRCC were identified using the Surveillance Epidemiology and End Results (SEER) (2004-2012) database and divided into groups based on their surgical treatment (ST): no surgery or radiation therapy (NSR); partial nephrectomy (PNE); radical nephrectomy with ureterectomy and bladder cuff resection (RNE + UE + BLAD); and radical nephrectomy (RNE). Certain radical nephrectomy cases also received adjuvant external-beam radiation therapy (RNE + RAD). The Kaplan-Meier method was used to estimate overall survival (OS). A multivariable competing risks regression analysis was used to calculate disease-specific survival (DSS) probability and to determine factors associated with cause-specific mortality (CSM). A total of 408 patients were included in this study. The 5-year OS and predicted DSS were significantly higher in the patients who underwent STs (i.e., PNE, RNE + UE + BLAD, RNE, and RNE + RAD) (20.1-54.0 and 20.1-59.9 %, respectively) than in the NSR group (9.0 and 11.6 %, respectively) (P < 0.001). ST was independently associated with a decreased CSM (P < 0.0001). No significant differences in OS or the 1-, 3-, or 5-year DSS probabilities between the RNE and RNE + RAD groups were observed. RNE + RAD was not significantly associated with a decrease in 1-year CSM [subhazard ratio (SHR) 0.95; 95 % CI 0.23-3.96; P = 0.947]. Adjuvant external-beam radiation therapy did not increase OS in non-metastatic sRCC patients.
    International Urology and Nephrology 08/2015; DOI:10.1007/s11255-015-1093-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: There are only scarce data on the optimal management of patients who present with a bladder carcinoma and who are aged 90 years and older. We retrospectively reviewed records from radiotherapy departments from two university hospitals, two private centers and one public center to identify patients who underwent radiotherapy for bladder cancer over the past decade and who were aged 90 years or older. From 2003 to 2013, 14 patients aged 90 years or older receiving RT for bladder malignant tumors were identified. Mean age was 92.7 years. Ten patients (71 %) had a general health status altered (PS 2-3) at the beginning of RT. A total of 14 RT courses were delivered, including six treatments (43 %) with curative intent and eight treatments (57 %) with palliative intent. Palliative intent mainly encompassed hemostatic RT (36 %). At last follow-up, two patients (14 %) experienced complete response, one patient (7 %) experienced partial response, three patients (21 %) had their disease stable, and three patients (21 %) experienced tumor progression, of whom two patients with the progression of symptoms. There was no reported high-grade acute local toxicity in 14 patients (100 %). One patient experienced delayed grade 2 toxicity with pain and lower urinary tract symptoms. At last follow-up, seven patients (50 %) were deceased. Cancer was the cause of death for five patients. Hypofractionated radiotherapy remains feasible for nonagenarians with bladder cancer. Further investigations including analysis of geriatric comorbidities and impact of treatments on quality of life should be conducted.
    International Urology and Nephrology 05/2015; 47(7). DOI:10.1007/s11255-015-0999-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hyperphosphatemia and metabolic acidosis are frequently encountered in advanced chronic kidney disease (CKD) patients. Correction of metabolic acidosis in patients with advanced CKD leads to a decrease in the progression of renal impairment and improves nutritional outcomes. Lanthanum carbonate is used for control of hyperphosphatemia. This study evaluated the effect of lanthanum carbonate on metabolic acidosis in CKD IV-V patients and in patients on dialysis. Retrospective data of patients in whom lanthanum carbonate therapy was initiated were collected from 2009 to 2013 in a single dialysis center. Of the 79 patients in whom lanthanum carbonate was introduced, 51 patients were included in the analysis. Of the 51 patients, 39 patients received chronic hemodialysis, two patients received peritoneal dialysis therapy, and 10 patients had stage IV-V CKD not on dialysis. The primary outcome was the serum bicarbonate change after the introduction of lanthanum carbonate. There was a significant increase in mean serum bicarbonate concentration of 2.79 mmol/L (p ≤ 0.001) compared to baseline. The increase remained in the CKD IV-V patients (2.50 mmol/L, p = 0.005) and in the patients on dialysis (2.81 mmol/L, p < 0.001). Serum bicarbonate remained higher (p > 0.05) than baseline up to 6 months after lanthanum carbonate introduction. In this study, lanthanum carbonate introduction increased serum bicarbonate concentration in a small sample of CKD IV-V patients and in patients on dialysis. Further studies are needed to confirm this effect and investigate whether the correction of metabolic acidosis by using lanthanum carbonate in CKD IV-V patients can improve clinical outcomes.
    International Urology and Nephrology 05/2015; 47(7). DOI:10.1007/s11255-015-1003-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Surveillance after orchiectomy alone has become popular in the management of clinical stage I nonseminomatous germ cell testicular tumors (CSI NSGCTT), and adjuvant chemotherapy has been accepted in high-risk CSI NSGCTT. Because of the late toxicity of standard radiotherapy in CSI testicular seminoma (SGCTT), this therapeutic approach has been accepted also in the management of CSI SGCTT. In the current study, we analyzed single-center experience with risk-adapted therapeutic approaches (active surveillance and adjuvant chemotherapy) in patients with CSI SGCTT. The study analyzed a total of 90 patients collected at a single center from April 2008 to March 2015 with CSI SGCTT who were stratified into two groups according to risk-adapted therapeutic approaches. In the group A (low-risk CSI SGCTT-no rete testis invasion, tumor size <4 cm, pT1 stage), which consisted of 74 patients who underwent surveillance, relapse occurred in seven (9.5 %) patients after a mean follow-up of 14.5 months. In the group B (high-risk CSI SGCTT-rete testis invasion, tumor size >4 cm or pT ≥ 2 stage), which consisted of 16 patients who were treated with adjuvant chemotherapy, relapse occurred in two (12.5 %) patients after a mean follow-up of 13.8 months. Overall survival of patients in both groups was 100 %. The statistically significant difference in progression-free survival between these two groups was not found. Radiotherapy is currently not recommended as an adjuvant treatment in CSI SGCTT patients. The benefit of using risk-adapted therapeutic approaches in CSI SGCTTs patients is evident.
    International Urology and Nephrology 05/2015; 47(7). DOI:10.1007/s11255-015-1002-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: In a paper recently published in this journal, Solak et al. [1] reported the high prevalence of interatrial block (IAB) in hemodialysis patients. The authors, however, excluded from their analysis diabetic patients and patients with multiple cardiovascular diseases, which nowadays represent a prominent fraction of hemodialysis population. In addition, the definition of IAB adopted in [1] does not meet the criteria established by Bayés de Luna et al. [2, 3]. In order to investigate the actual prevalence of IAB in hemodialysis patients, we consider all the outpatients on hemodialysis treatment (bicarbonate dialysis or HDF) three times a week in two facilities of Maria Rosaria Clinic Group (Pompeii, Italy). The patients’ comorbidities and drug therapies have been derived from computerized medical records, and an ECG has been performed before the mid-week hemodialysis session and then digitalized. After discarding six patients due to the lack of sinus rhythm (in five of them the ECG ...
    International Urology and Nephrology 01/2015; 47(3). DOI:10.1007/s11255-015-0914-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: To evaluate the effects of presence of hydronephrosis on micropercutaneous nephrolithotomy (micro-PNL) surgery. Patients and methods: A retrospective analysis of 112 patients who underwent microperc surgery between December 2012 and April 2014 was performed. Patients were evaluated in two groups according to whether the presence of hydronephrosis. Stone size and location, fluoroscopy and operation time, stone-free rates and patient-related parameters were prospectively recorded into a centralized computer-generated system. Results: A total of 58 patients in Group 1 with hydronephrosis and 54 patients in Group 2 with no hydronephrosis were analyzed. There was no statistically significant difference in terms of stone sizes and body mass indexes (BMI) in comparison of groups (155.2 ± 93.06 vs. 143.70 ± 70.77 mm(2), p = 0.856 and 27.6 ± 4.2 vs. 26.7 ± 3.2 kg/m(2), p = 0.625). The success rates were similar (91.3 vs. 92.5%, p = 0.341). While the mean operation time and fluoroscopy time in Group 1 were 44.2 ± 23.62 min and 105.3 ± 47 s, it was 38.8 ± 26.4 min and 112.53 ± 68.3 s in Group 2, but there was no statistical difference in comparison of both groups. The mean attempts of percutan puncture were 1.35 ± 0.47 in Group 1 and 1.76 ± 0.31 in Group 2 (p = 0.185). We also found no statistical differences regarding mean hemoglobin change and hospitalization time, respectively (p = 0.685 and p = 0753). In comparison of grades of hydronephrosis, there was no statistically significant difference in subgroups analysis. Conclusions: The presence of hydronephrosis does not affect success rates and operative time in micro-PNL procedures significantly. Micropercutaneous nephrolithotomy is technically feasible and efficacious both in hydronephrotic and non-hydronephrotic kidneys.
    International Urology and Nephrology 01/2015; 47(3). DOI:10.1007/s11255-014-0907-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose In the current analysis due to the mechanism of effect, we evaluated the treatment benefit of duloxetine 40 mg comparing with paroxetine 20 mg, based on its effects on personal distress and interpersonal difficulty related to ejaculation, perceived control over ejaculation, and satisfaction with sexual intercourse, as well as the patient-reported global impression of change in premature ejaculation (PE) and the effect on intravaginal ejaculatory latency times (IELT) in men with premature ejaculation. Materials and methods The study included 80 married male patients diagnosed with lifelong PE. A total of 80 patients were randomly distributed into two groups of 40 patients each. Group 1 patients received 40 mg duloxetine once a day for a month. Group 2 patients received 20 mg paroxetine once a day for a month. International index of erectile function questionnaire (IIEF) and IELT and PE profile were recorded before and after treatment. Results Comparing the groups’ mean treatment IELT, there was no difference between groups. The IELT increase from baseline to treatment was 117 % in the duloxetine group (P
    International Urology and Nephrology 01/2015; 47(2). DOI:10.1007/s11255-014-0905-9
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose No safe ultrasound (US) parameters have been established to differentiate the causes of graft dysfunction. Objectives To define US parameters and identify the predictors of normal graft evolution, delayed graft function (DGF), and rejection at the early period after kidney transplantation. Methods Between June 2012 and August 2013, 79 renal transplant recipients underwent US examination 1–3 days posttransplantation. Resistive index (RI), power Doppler (PD), and RI + PD (quantified PD) were assessed. Patients were allocated into three groups: normal graft evolution, DGF, and rejection. Results Resistive index of upper and middle segments and PD were higher in the DGF group than in the normal group. ROC curve analysis revealed that RI + PD was the index that best correlated with DGF (cutoff = 0.84). In the high RI + PD group, time to renal function recovery (6.33 ± 6.5 days) and number of dialysis sessions (2.81 ± 2.8) were greater than in the low RI + PD group (2.11 ± 5.3 days and 0.69 ± 1.5 sessions, respectively), p = 0.0001. Multivariate analysis showed that high donor final creatinine with a relative risk (RR) of 19.7 (2.01–184.7, p = 0.009) and older donor age (RR = 1.17 (1.04–1.32), p = 0.007) correlated with risk DGF. Conclusions Quantified PD (RI + PD) was the best DGF predictor. PD quantification has not been previously reported .
    International Urology and Nephrology 12/2014; 47(2). DOI:10.1007/s11255-014-0896-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose To evaluate the mortality and morbidity prediction capability of three different scoring systems: Fournier’s gangrene severity index (FGSI), Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) and neutrophile–lymphocyte ratio (NLR) with this retrospective cohort study. Methods Medical records of all patients treated for FG with the final histopathological diagnosis between October 2008 and January 2013 were retrospectively evaluated. Data were collected from medical history, physical examination findings, biochemical and microbiological tests and tissue cultures. FGSI and LRINEC scores and NLR were determined for all patients. Then, it was explored whether higher FGSI (
    International Urology and Nephrology 12/2014; 47(2). DOI:10.1007/s11255-014-0897-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Home-based exercise has been shown to provide benefits in terms of physical capacity in the general population, but has been scarcely investigated in patients with chronic kidney disease (CKD). Aims To evaluate the impact of a home-based aerobic training on the cardiopulmonary and functional capacities of overweight non-dialysis-dependent patients with CKD (NDD-CKD). Methods Twenty-nine sedentary patients (55.1 ± 11.6 years, BMI = 31.2 ± 6.1 kg/m2, eGFR = 26.9 ± 17.4 mL/min/1.73 m2) were randomly assigned to a home-based exercise group (n = 14) or to a control group (n = 15) that remained without performing exercise. Aerobic training was performed three times per week for 12 weeks. A cardiopulmonary exercise test, functional capacity and clinical parameters were evaluated. Results A significant increase, ranging from 8.3 to 17 %, was observed in the cardiopulmonary capacity parameters, such as maximal ventilation (p = 0.005), VO2peak (p = 0.049), ventilatory threshold (p = 0.040) and respiratory compensation point (p p p p p p p = 0.042)] was also found in patients who were submitted to the exercise. Exercised patients experienced a decrease in systolic and diastolic blood pressure, average 10.6 % (p p = 0.007), respectively, and a trend toward improved renal function (p = 0.1). No change in any parameter was found in the control group during the follow-up. Conclusion The home-based aerobic exercise program was feasible, safe and effective for the improvement in the cardiopulmonary and functional capacities of overweight NDD-CKD patients.
    International Urology and Nephrology 12/2014; 47(2). DOI:10.1007/s11255-014-0894-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: Because more than 70 % of patients with localized tumors experience 10 years of cancer-specific survival, their quality of life (QoL) after surgery is important. The aim of this study was to explore the impact of the type of surgery (partial vs. total nephrectomy) and the postoperative outcome on the QoL of patients with renal cancer. Methods: A total of 205 patients underwent partial or total nephrectomy at the Department of Urology, Roskilde Hospital, between February 2008 and June 2013 and survived until the time of the survey. The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) was sent to this cohort in January 2014. Results: The response rate was 74.1 % for complete answers. The overall global health status (QoL) was low (69.12 %) for all patient groups, regardless of the operation technique and the underlying medical status. Total nephrectomy was a negative predictor of QoL, physical functioning, role functioning, and fatigue. Patients who experienced recurrence reported significant deterioration in 11 of the 15 EORTC QLQ-C30 domains. Additionally, thinking about cancer only during the follow-up visit was associated with a significant decrease in emotional functioning and role functioning compared with never thinking about one's cancer. Conclusion: Total nephrectomy was a negative predictor of overall global health status. There is a demand for a reasonable follow-up program with an individual control interval according to the risk of recurrence and the possibility of treatment as well as the patient's discretion.
    International Urology and Nephrology 12/2014; 47(2). DOI:10.1007/s11255-014-0893-9